Home   News   Article

New King's Lynn hospital technology to decontaminate Covid-19 micro-organisms




Lynn's Queen Elizabeth Hospital (QEH) has innovative ultraviolet-C (UV-C) decontamination technology as part of a new partnership which will help prevent Covid-19 spreading.

The ‘Ultra-V’ technology was designed by Lynn-based infection prevention and control company, Inivos, to fully decontaminate healthcare settings of pathogenic micro-organisms.

These micro-organisms include C.Difficile, Staphylococcus Aureus and the SARS-CoV-2 pathogen which causes Covid-19.

The Queen Elizabeth Hospital in King’s Lynn has secured innovative ultraviolet-C (UV-C) decontamination technology. Picture: QEH
The Queen Elizabeth Hospital in King’s Lynn has secured innovative ultraviolet-C (UV-C) decontamination technology. Picture: QEH

Libby McManus, chief nurse, said: “We are so grateful to Inivos for supplying this incredible piece of kit to the QEH. Working with this innovative equipment will support our domestic services teams to deep clean patient areas quicker, in turn allowing us to care for more patients.

“We are looking forward to developing our relationship with Inivos and hopefully launch some research and development projects with them in the future.”

Using light generated by 10 UV-C lamps, the Ultra-V can decontaminate a space of potentially dangerous microorganisms in as little as 10 minutes.

The equipment is calibrated by specialist monitoring technology called spectromes.

Six spectromes are placed in different areas in the room to constantly record the level of UV being transmitted throughout the process.

Each spectrome reports back to a central tablet which creates auto-generated reports in real-time, allowing hospital staff to be confident that a cycle has been successful and the environment is safe to inhabit.

Donna Mason, domestic service manager, said: “The department is very excited to receive this equipment. This piece of equipment will allow the department to enhance the deep cleaning process and reduce the risk of infection.”

Tautvydas Karitonas, head of research and development at Inivos, said: “As a local company, we’re proud to partner with the Queen Elizabeth Hospital to support their incredible staff in providing the highest possible quality of care to local residents.”



This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More